New Delhi : The Drugs Controller General (India) Dr V. G. Somani has constituted a Committee to have a comprehensive “National Drugs Database” vide office memorandum F. No. ED/Misc./365/2022 dated 27.10.2022 of following members:-
- Dr. HG Koshia, Commissioner, FDCA, Gujarat
- Sh. AK Pradhan, JDC (I), Convenor
- Dr. Pooja Gupta, Addl. Professor, AIIMS, New Delhi
- Dr Jerian Jose, Scientist D, ICMR, New Delhi
- Sh. DR Gahane, JC, FDA, Maharashtra
- Sh. BT Khanapure, SDC, Karnataka and
- Sh. Navneet Marwaha, SDC, HP
This decision is taken to have a comprehensive database of drug formulations manufactured/ marketed in the country providing detailed information on the drug, its dosage form, strength, details of manufacturer/ marketer/importer etc. This will not only empower the consumers but also for improving the monitoring mechanism for quality of drugs in circulation, across the country and uniform administration of the regulatory system.
The committee will examine the existing database available with various Authorities like States/UT Drugs Control Depts, CDSCO, various manufacturer/ marketer/importer.
The committee will give recommendations & Prepare a comprehensive “National Drugs Database” of drug formulations manufactured/ marketed in the country providing detailed information on the drug, its dosage form, strength, details of manufacturer/ marketer/importer etc.
The committee may co opt any other expert, as deemed necessary.
The committee will submit its recommendations including “National Drugs Database” in three months.
